<DOC>
	<DOCNO>NCT01486745</DOCNO>
	<brief_summary>This prospective , multi-centered study ass whether urine metabolomics play role screen colorectal cancer ( CRC ) . Urine sample collect 1000 patient go establish CRC screen program , 500 patient already diagnosis CRC . Using nuclear magnetic resonance ( NMR ) spectroscopy , 1H NMR spectrum urine sample analyze specific metabolite , establish metabolomic signature colorectal cancer . The result metabolomic urinalysis screen cohort compare result colonoscopy , histological description , fecal occult blood testing ( FOBT ) , fecal immune test ( FIT ) ass accuracy urine metabolomics identify patient polyps malignancy . The urine metabolomic result colorectal cancer group correlate operative , histological clinical stag define role urine metabolomics assess colorectal cancer type , location stage . Additionally approximately 300 urine sample breast cancer patient 300 prostate cancer patient collect validate colorectal cancer signature unique .</brief_summary>
	<brief_title>Urine Metabolomics Colorectal Cancer Screening</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<criteria>For Screening group ( normal colonoscopy &amp; colonic polyp ) : asymptomatic , 5075 year old , without personal family history CRC/polyps asymptomatic , 4075 year old , know personal firstdegree family history either CRC polyp For Cancer group : patient diagnosis colorectal cancer patient diagnosis prostate cancer patient diagnosis breast cancer For screen group : hematochezia inflammatory bowel disease anticoagulation reason atrial fibrillation significant comorbidities For Cancer group : already neoadjuvant treatment time urine collection invasive cancer time urine collection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>